SIGNPATH PHARMA INC. Private Placement of Units PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • April 9th, 2015 • SignPath Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 9th, 2015 Company Industry JurisdictionSignPath Pharma Inc., a Delaware corporation (the “Company”) proposes to offer for sale (the “Offering”) in a private offering pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and Rule 506 of Regulation D promulgated thereunder, a $3,000,000 no minimum basis (the Maximum Offering”) of units (“Units”), with a $2,000,000 Over-Subscription Option. Each Unit offered at $1,000 consists of (i) one share of Series D Convertible Preferred Stock convertible into 500 shares of Common Stock issuable at $2.00 per share, and (ii) Class D Warrants exercisable at $3.00 per share (the “Warrants”) to purchase an aggregate of 125 shares of Common Stock. The Units are being offered during an offering period commencing on the date hereof and expiring December 16, 2014 [90 days from the date the Offering commences], unless mutually extended or terminated by the Company and Meyers Associates L.P. (“Meyers” or the “Placement Agent”), or earlier if all of the Units are sold (
SIGNPATH PHARMA INC. Private Placement of Units PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 31st, 2014 • SignPath Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 31st, 2014 Company Industry JurisdictionSignPath Pharma Inc., a Delaware corporation (the “Company”) proposes to offer for sale (the “Offering”) in a private offering pursuant to Section 4(a)(2) and/or Section 4(a)(6) of the Securities Act of 1933, as amended (the “Act”), and Rule 506 of Regulation D promulgated thereunder, a $3,000,000 no minimum basis (the Maximum Offering”) of units (“Units”), with a $2,000,000 Over-Subscription Option. Each Unit offered at $1,000 consists of (i) one share of Series C Convertible Preferred Stock convertible into 800 shares of Common Stock issuable at $1.25 per share, and (ii) 400 Class C Warrants exercisable at $1.875 per share (the “Warrants”) to purchase an aggregate of 400 shares of Common Stock. The Units are being offered during an offering period commencing on the date hereof and expiring on June 30, 2013, unless mutually extended by the Company and Meyers Associates L.P. (the “Placement Agent”). This Agreement shall confirm our agreement concerning Meyers Associates L.P. acting as
SIGNPATH PHARMA, INC. Private Placement of Units PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 24th, 2009 • SignPath Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 24th, 2009 Company Industry JurisdictionSignPath Pharma, Inc., a Delaware corporation (the “Company”) proposes to offer for sale (the “Offering”) in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended (the “Act”), and/or Regulation D promulgated thereunder, an aggregate of up to $4,000,000 of units of its securities (“Units”) (plus $2,000,000 of additional Units to cover oversubscriptions). Each Unit consists of one share of Series A Preferred Stock (the “Preferred Shares”) and one Common Stock Purchase Warrant (the “Warrants”). Each Warrant will entitle the holder thereof to purchase 1,177 shares of the Company’s Common Stock. The Units, Preferred Shares and Warrants are sometimes referred to herein as the “Securities.” The Offering is being conducted on a “best efforts all or none” basis with respect to minimum gross proceeds of $1,500,000 (the “Minimum Offering”), and on a “best efforts” basis as to the remaining $2,500,000 of the maximum $4,000,000 gross proceeds (or $6,000,000 in the ev
VISION ACQUISITION II, INC. Private Placement of Units PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • March 25th, 2008 • Vision Acquisition II, Inc • Blank checks • New York
Contract Type FiledMarch 25th, 2008 Company Industry JurisdictionVision Acquisition II, Inc., a Delaware corporation (the “Company”) proposes to offer for sale (the “Offering”) in a private offering pursuant to Section 4(2) and/or Section 4(6) of the Securities Act of 1933, as amended (the “Act”), and Rule 506 of Regulation D promulgated thereunder, a minimum of $8,000 (the “Minimum Offering”) of units (“Units”). Each Unit consists of 10,000 shares of Common Stock, par value $.0001 per share (the “Common Stock”). Each investor (“Investor”) may purchase only one Unit at a per Unit price of $200, or $.02 per share. The Units are being offered during an offering period commencing on the date hereof and expiring the earliest of: (i) 60 days thereafter, unless extended by the Company and the Placement Agent (defined below) for up to an additional sixty (60) days; (ii) the sale of Units constituting at least the Minimum Offering, or (iii) the termination of the Offering by the Company and the Placement Agent (such period, as same may be extended, being he
CHINA MOBILITY SOLUTOINS, INC. Private Placement of Units PLACEMENT AGENCY AGREEMENT Dated as of June 30, 2005Placement Agency Agreement • May 9th, 2006 • CHINA MOBILITY SOLUTIONS, INC. (Formerly Xin Net Corp.) • Services-computer processing & data preparation • New York
Contract Type FiledMay 9th, 2006 Company Industry JurisdictionChina Mobility Solutions, Inc., a Florida corporation (the “Company”) proposes to offer for sale (the “Offering”) in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended (the “Act”), and/or Regulation D promulgated thereunder, an aggregate of $2,000,000 of units (“Units”) (plus $1,000,000 of additional Units to cover over-subscriptions). Each Unit consists of a $25,000 principal amount of 6% convertible debentures (the “Debentures”), Class A Common Stock Purchase Warrants (the “Class A Warrants”) and Class B Common Stock Purchase Warrants (the “Class B Warrants” and together with the Class A Warrants, the “Warrants”). The Units, Debentures, Class A Warrants and Class B Warrants are sometimes referred to herein as the “Securities.” The Units are being offered on a “best efforts all or none” basis as to the entire $2,000,000 of Units (the “Offering Amount”) during an offering period commencing on the date hereof and expiring 60 days thereafter, unless ext